International Clinics
Daily
Experimental obesity drug retatrutide halved knee arthritis pain in two-thirds of patients in two large trials
In two phase 3 trials with more than 1,000 patients, the experimental drug retatrutide cut knee osteoarthritis pain by at least half in about two-thirds of people, versus 38% on placebo.




